About Polymer Factory
Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors and CEO have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.

Polymer Factory’s dendritic nanotechnologies have the potential of accelerating innovation in material and life science sectors, particularly through the availability of precision dendritic products that can enhance and amplify a desired property that is underperforming by the Company’s customers, for example in diagnostics, by carrying colorants and enhancing detection of diseases, or in tissue engineering by contributing to improved tissue growth. There is also growing demand for accurate calibration to enable faster and more precise analysis of chemical and biological substances in water, food, commercial/industrial products, and biological samples from patients, while at the same time ensuring that sharper and more demanding regulations are met.

Since the founding of the Company, its management has primarily been engaged in research activities and has dedicated limited time to Polymer Factory’s operations. Revenues have consequently been based on incoming requests and purchase orders – the Company has done little in the area of proactive sales. Despite this, there has been significant interest from a large number of multinationals, and stable revenue streams. With proceeds from this capitalization, there is an opportunity to significantly expand the business and sales organization and accelerate the Company’s growth.  Therefore, Polymer Factory is now conducting an issue of units (shares and free of charge warrants) amounting to approx. SEK 18.2 million (before issue costs), prior to listing at Spotlight Stock Market. Funds from the new issue will enable the Company to make key recruitments in sales, business and product development, while significantly growing its presence in important markets. Investments will also be made in an additional research facility to expand in-house product development. In addition, part of the funds will be used to strengthen the Company’s patent portfolio, as well as gaining necessary accreditations.

Listing at Spotlight Stock Market
Polymer Factory is approved for listing at Spotlight Stock Market, provided that the new issue’s minimum limit (approx. 80 percent) is reached, and that Spotlight Stock Market’s ownership distribution requirements are met.

Summary of the offer:

Subscription period: February 25 – March 11, 2021.
Subscription price: Each unit consists of 3 shares and 1 attached free warrant. Price per unit is SEK 22.80, corresponding to a price per share of SEK 7.60.
Subscription post: The minimum subscription post is 240 units (corresponding to SEK 5,472).
Issue volume: Initially approx. SEK 13 million (before issue costs of approx. SEK 1.28 million), of which approx. SEK 0.37 million is attributable to compensation (in the form of units) for previously received bridge loans and will thus not be provided to the Company. 
In addition, approx. SEK 1.8 million pertains to the bridge loan which, just like the compensation, is to be set off in the issue. 
Upon full exercise of warrants of series TO 1, the Company can be provided with additionally approx. SEK 5.2 million before issue costs, which correspond to SEK 0.5 million.
Number of shares before the issue of units: 5,155,000 shares.
Valuation (pre-money): Approx. SEK 39.2 million.
Subscription commitments: The Company has received subscription commitments corresponding to approximately SEK 6.5 million (including bridge financing and compensation for bridge financing).
ISIN-code for the share: SE0015244470 
Expected first day of trading on Spotlight Stock Market: April 7, 2021

Advisors
Polymer Factory has in connection with the issue of units appointed Sedermera Fondkommission as financial advisor, Markets & Corporate Law Nordic AB as the legal advisor, and Nordic Issuing as issuing agent.

For additional information on the issue of units, please contact:
Sedermera Fondkommission
Phone: +46 (0) 40-615 14 10
E-mail: info@sedermera.se

For more information about Polymer Factory, please contact:
Michael Malkoch, CEO
Phone: +46 (0) 70 221 18 75
E-mail: michael.malkoch@polymerfactory.com

Polymer Factory is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.